These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 304670)

  • 41. Neurobehavioural and psychiatric manifestations in a case of ANA-negative SLE with antiphospholipid antibodies.
    Zoli A; Altomonte L; Galossi A; Taranto A; Mirone L; Magaró M
    Clin Rheumatol; 1998; 17(1):68-70. PubMed ID: 9586684
    [No Abstract]   [Full Text] [Related]  

  • 42. Antinuclear antibodies in pleural fluid.
    Khare V; Baethge B; Lang S; Wolf RE; Campbell GD
    Chest; 1994 Sep; 106(3):866-71. PubMed ID: 8082370
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Autoimmune response of IgE antibodies to cellular self-antigens in systemic Lupus Erythematosus.
    Atta AM; Santiago MB; Guerra FG; Pereira MM; Sousa Atta ML
    Int Arch Allergy Immunol; 2010; 152(4):401-6. PubMed ID: 20197682
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diagnostic and prognostic significance of different antinuclear antibodies in more than 1000 consecutive Albanian patients with rheumatic diseases.
    Sulcebe G; Morcka K
    Clin Exp Rheumatol; 1992; 10(3):255-61. PubMed ID: 1582070
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Primary biliary cirrhosis and systemic lupus erythematosus. A rare association.
    Schifter T; Lewinski UH
    Clin Exp Rheumatol; 1997; 15(3):313-4. PubMed ID: 9177929
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antinuclear antibodies as immunologic markers for a benign subset and different clinical characteristics of scleroderma.
    Kleinsmith DM; Heinzerling RH; Burnham TK
    Arch Dermatol; 1982 Nov; 118(11):882-5. PubMed ID: 6753766
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serological and clinical remission in systemic lupus erythematosus.
    Heller CA; Schur PH
    J Rheumatol; 1985 Oct; 12(5):916-8. PubMed ID: 3878878
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Specific antinuclear antibodies are associated with clinical features in systemic lupus erythematosus.
    Hoffman IE; Peene I; Meheus L; Huizinga TW; Cebecauer L; Isenberg D; De Bosschere K; Hulstaert F; Veys EM; De Keyser F
    Ann Rheum Dis; 2004 Sep; 63(9):1155-8. PubMed ID: 15308527
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vivo antinuclear antibodies (ANA) in biopsies of normal skin: diagnostic significance and relation to serum ANA.
    Kallenberg CG; de Jong MC; Walstra TM; Kardaun S; The TH
    J Rheumatol; 1983 Oct; 10(5):733-40. PubMed ID: 6606041
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Digital ulcers/gangrene and immunoglobulin classes/complement fixation of anti-dsDNA in systemic lupus erythematosus patients.
    Hashimoto H; Tsuda H; Takasaki Y; Fujimaki N; Suzuki M; Shiokawa Y
    J Rheumatol; 1983 Oct; 10(5):727-32. PubMed ID: 6606040
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The autoantibody profile and disease activity in patients with systemic lupus erythematosus].
    Horák P; Hermanová Z; Faltýnek L; Pospísil Z; Scudla V
    Vnitr Lek; 1997 Oct; 43(10):639-44. PubMed ID: 9601876
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Raynaud's phenomenon - first sign of malignancy: case report].
    Sutić A; Gračanin G; Morović-Vergles J
    Acta Med Croatica; 2014 Jun; 68(3):295-8. PubMed ID: 26016221
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Clinical significance of antinuclear antibody in patients with idiopathic thrombocytopenic purpura].
    Kurata Y; Miyagawa S; Kosugi S; Kashiwagi H; Honda S; Mizutani H; Tomiyama Y; Kanayama Y; Matsuzawa Y
    Rinsho Ketsueki; 1992 Sep; 33(9):1178-82. PubMed ID: 1433939
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Carbamazepine-induced antinuclear antibodies and systemic lupus erythematosus-like syndrome.
    De Giorgio CM; Rabinowicz AL; Olivas RD
    Epilepsia; 1991; 32(1):128-9. PubMed ID: 1985821
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Case report. Two cases of pulmonary hypertension with Raynaud's phenomenon. Primary pulmonary hypertension and systemic lupus erythematosus.
    Kanemoto N; Gonda N; Katsu M; Fukuda J
    Jpn Heart J; 1975 May; 16(3):354-60. PubMed ID: 1160186
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical manifestations and vascular events in patients with lupus erythematosus anticardiolipin antibodies and raynaud's phenomenon.
    Rodriguez VE; Gonzalez-Pares EN; Rivera C
    P R Health Sci J; 2006 Dec; 25(4):307-13. PubMed ID: 17550096
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Does sulphasalazine cause drug induced systemic lupus erythematosus? No effect evident in a prospective randomised trial of 200 rheumatoid patients treated with sulphasalazine or auranofin over five years.
    Gordon MM; Porter DR; Capell HA
    Ann Rheum Dis; 1999 May; 58(5):288-90. PubMed ID: 10225813
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chilblain lupus erythematosus is associated with antibodies to SSA/Ro.
    Franceschini F; Calzavara-Pinton P; Quinzanini M; Cavazzana I; Bettoni L; Zane C; Facchetti F; Airò P; McCauliffe DP; Cattaneo R
    Lupus; 1999; 8(3):215-9. PubMed ID: 10342714
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical significance of anti-nDNA antibodies in ANA-positive systemic lupus erythematosus: comparison of the Farr radioimmunoassay and the Crithidia luciliae immunofluorescent technique.
    Chuan MT; Wu YC; Ang ET; Wang JH; In KL; Lü YC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1985 Feb; 18(1):15-24. PubMed ID: 3896689
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lupus patients who lack detectable anti-DNA: clinical features and survival.
    Ballou SP; Kushner I
    Arthritis Rheum; 1982 Sep; 25(9):1126-9. PubMed ID: 6982045
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.